Is mechanical dyssynchrony a therapeutic target in heart failure with preserved ejection fraction?

被引:16
|
作者
Menet, Aymeric [1 ]
Greffe, Lorraine [1 ]
Ennezat, Pierre-Vladimir [2 ]
Delelis, Francois [1 ]
Guyomar, Yves [1 ]
Castel, Anne Laure [1 ]
Guiot, Aurelie [1 ]
Graux, Pierre [1 ]
Tribouilloy, Christophe [3 ,4 ]
Marechaux, Sylvestre [1 ,4 ]
机构
[1] Univ Lille Nord France, GCS Groupement Hop, Inst Catholique Lille, Fac Libre Med,Univ Catholique Lille, Lille, France
[2] CHU Grenoble, Grenoble, France
[3] CHU Amiens, Pole Cardiovasc & Thorac, Amiens, France
[4] Univ Picardie, INSERM, U1088, Amiens, France
关键词
CARDIAC-RESYNCHRONIZATION THERAPY; LEFT-VENTRICULAR DYSSYNCHRONY; BUNDLE-BRANCH BLOCK; EUROPEAN-SOCIETY; TASK-FORCE; COLLABORATION; PREVALENCE; GUIDELINES; ASYNCHRONY; SURVIVAL;
D O I
10.1016/j.ahj.2014.08.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Previous studies have found a high frequency of mechanical dyssynchrony in patients with heart failure (HF) with preserved ejection fraction (HFpEF), hence suggesting that cardiac resynchronization therapy (CRT) may be considered in HFpEF. The present study was designed to compare the amount of mechanical dyssynchrony between HFpEF patients and (1) HF with reduced EF (HFrEF) patients with an indication for CRT (HFrEF-CRT(+)) group, (2) HFrEF patients with QRS duration <120 ms (HFrEF-QRS <120 ms) group, and (3) hypertensive controls (HTN). Methods Electrical (ECG) and mechanical dyssynchrony (atrio-ventricular dyssynchrony, interventricular dyssynchrony, intraventricular dyssynchrony) were assessed using conventional, tissue Doppler, and Speckle Tracking strain echocardiography in 40 HFpEF patients, 40 age-and sex-matched HTN controls, 40 HFrEF-QRS <120 ms patients, and 40 HFrEF-CRT(+) patients. Results The frequency of left bundle branch block was low in HFpEF patients (5%) and similar to HTN controls (5%, P = 0.85). Indices of dyssynchrony were similar between HFpEF and HTN patients or HFrEF-QRS <120 ms patients. In contrast, most indices of dyssynchrony differed between HFpEF and HFrEF-CRT(+) patients. The principal components analysis on the entire cohort of 160 patients yielded 2 homogeneous groups of patients in terms of dyssynchrony, the first comprising HFrEF-CRT(+) patients and the second comprising HTN, HFrEF-QRS <120 ms and HFpEF patients. Conclusions Mechanical dyssynchrony in HFpEF does not differ from that of patients with HTN or patients with HFrEF and a narrow QRS. This data raises concerns regarding the role of dyssynchrony in the pathophysiology of HFpEF and thereby the potential usage of CRT in HFpEF.
引用
收藏
页码:909 / +
页数:9
相关论文
共 50 条
  • [21] Looking Ahead to Target Heart Failure With Preserved Ejection Fraction
    Bialek, Marie
    AMERICAN JOURNAL OF MANAGED CARE, 2016, 22 : 7 - 8
  • [22] Looking Ahead to Target Heart Failure With Preserved Ejection Fraction
    Bialek, Marie
    AMERICAN JOURNAL OF MANAGED CARE, 2016, 22 : 7 - 8
  • [23] Current Therapeutic Approach in Heart Failure with Preserved Ejection Fraction
    Nativi-Nicolau, Jose
    Ryan, John J.
    Fang, James C.
    HEART FAILURE CLINICS, 2014, 10 (03) : 525 - +
  • [24] The therapeutic potential of relaxin for heart failure with preserved ejection fraction
    Salama, G.
    Palma, J.
    Gabris-Weber, B.
    MacMahon, B.
    Kuhn, B.
    Dschietzig, T.
    Romero, G.
    EUROPEAN HEART JOURNAL, 2022, 43 : 777 - 777
  • [25] Low Fitness in Midlife: A Novel Therapeutic Target for Heart Failure with Preserved Ejection Fraction Prevention
    Pandey, Ambarish
    Darden, Douglas
    Berry, Jarett D.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2015, 58 (01) : 87 - 93
  • [26] Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target
    Glezeva, N.
    Baugh, J. A.
    HEART FAILURE REVIEWS, 2014, 19 (05) : 681 - 694
  • [27] Electrical Phenotype in Heart Failure With Preserved Ejection Fraction Disease Severity Marker or Therapeutic Target?
    Kaye, David M.
    Patel, Hitesh C.
    JACC-HEART FAILURE, 2019, 7 (05) : 428 - 430
  • [28] Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target
    N. Glezeva
    J. A. Baugh
    Heart Failure Reviews, 2014, 19 : 681 - 694
  • [29] Interatrial Dyssynchrony May Contribute to Heart Failure Symptoms in Patients with Preserved Ejection Fraction
    Sanchis, Laura
    Vannini, Luca
    Gabrielli, Luigi
    Duchateau, Nicolas
    Falces, Carles
    Andrea, Rut
    Bijnens, Bart
    Sitges, Marta
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2015, 32 (11): : 1655 - 1661
  • [30] Heart failure with preserved ejection fraction
    Kessler, Kenneth M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (17): : 1829 - 1829